[go: up one dir, main page]

WO1993016178A3 - Sequences caracteristiques du produit de transcription des genes humains - Google Patents

Sequences caracteristiques du produit de transcription des genes humains Download PDF

Info

Publication number
WO1993016178A3
WO1993016178A3 PCT/US1993/001294 US9301294W WO9316178A3 WO 1993016178 A3 WO1993016178 A3 WO 1993016178A3 US 9301294 W US9301294 W US 9301294W WO 9316178 A3 WO9316178 A3 WO 9316178A3
Authority
WO
WIPO (PCT)
Prior art keywords
human gene
gene transcription
transcription product
sequences characteristic
sequences
Prior art date
Application number
PCT/US1993/001294
Other languages
English (en)
Other versions
WO1993016178A2 (fr
Inventor
Craig J Venter
Mark D Adams
Ruben F Moreno
Original Assignee
Us Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Army filed Critical Us Army
Publication of WO1993016178A2 publication Critical patent/WO1993016178A2/fr
Publication of WO1993016178A3 publication Critical patent/WO1993016178A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Séquences d'ADNc humain et géniques partielles et complètes correspondant à des marques séquencielles exprimées particulières. Les marques séquencielles exprimées qui sont des séquences d'ADNc dont la longueur varie généralement entre 150 et 500 paires de bases sont dérivées de banques d'ADNc du cerveau humain, correspondent à des gènes transcrits dans le cerveau humain et possèdent des séquences de base désignées ici par les no. d'identification 1-2421.
PCT/US1993/001294 1992-02-12 1993-02-12 Sequences caracteristiques du produit de transcription des genes humains WO1993016178A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83719592A 1992-02-12 1992-02-12
US07/837,195 1992-02-12

Publications (2)

Publication Number Publication Date
WO1993016178A2 WO1993016178A2 (fr) 1993-08-19
WO1993016178A3 true WO1993016178A3 (fr) 1993-11-25

Family

ID=25273788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/001294 WO1993016178A2 (fr) 1992-02-12 1993-02-12 Sequences caracteristiques du produit de transcription des genes humains

Country Status (2)

Country Link
AU (1) AU3665893A (fr)
WO (1) WO1993016178A2 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8116494A (en) * 1993-11-12 1995-06-13 Kenichi Matsubara Gene signature
AU1322795A (en) 1993-12-24 1995-07-17 Erasmus University Rotterdam Tuberous sclerosis 2 gene and uses thereof
US5605797A (en) * 1994-09-15 1997-02-25 Board Of Trustees Operating Michigan State University Bovine β-mannosidase gene and methods of use
US5863744A (en) * 1994-10-03 1999-01-26 New England Deaconess Hospital Corporation Neural cell protein marker RR/B and DNA encoding same
US7175995B1 (en) 1994-10-27 2007-02-13 Thomas Jefferson University TCL-1 protein and related methods
US5985598A (en) * 1994-10-27 1999-11-16 Thomas Jefferson University TCL-1 gene and protein and related methods and compositions
US5985554A (en) * 1994-11-02 1999-11-16 Takeda Chemical Industries, Ltd. Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
CA2225824A1 (fr) * 1995-06-30 1997-01-23 Human Genome Sciences, Inc. Genes et proteines specifiques au sein
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
AU4105396A (en) 1995-11-02 1997-05-29 Human Genome Sciences, Inc. Mammary transforming protein
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6509170B1 (en) 1996-03-14 2003-01-21 Human Genome Sciences, Inc. Polynucleotides encoding human tumor necrosis factor delta
US6468766B1 (en) 1996-03-15 2002-10-22 President And Fellows Of Harvard College Aortic carboxypeptidase-like polypeptide
WO1997042218A1 (fr) * 1996-05-06 1997-11-13 Chiron Corporation GENE MAMMALIEN Scm A EFFET ONCOGENE
AU2936497A (en) * 1996-05-08 1997-11-26 Chiron Corporation Mammalian additional sex combs (mammalian asx) acts as a tumor suppressor
CA2257839C (fr) 1996-07-12 2012-10-23 Genentech, Inc. Gamma-hereguline
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US5917028A (en) * 1996-10-29 1999-06-29 Incyte Pharmaceuticals, Inc. Human phosphoprotein
US5840559A (en) * 1996-10-30 1998-11-24 Incyte Pharmaceuticals, Inc. Human spermidine/spermine N1-acetyltransferase
US5889170A (en) * 1997-01-31 1999-03-30 Incyte Pharmaceuticals, Inc. Human integral membrane protein
US5939271A (en) * 1997-02-19 1999-08-17 The Regents Of The University Of California Netrin receptor
US5955312A (en) * 1997-02-24 1999-09-21 Incyte Pharmaceuticals, Inc. DNA encoding a novel microtubule-associated protein
EP0968287A2 (fr) * 1997-02-26 2000-01-05 Genetics Institute, Inc. Proteines secretees et polynucleotides codant pour celles-ci
US6171787B1 (en) * 1997-06-26 2001-01-09 Abbott Laboratories Member of the TNF family useful for treatment and diagnosis of disease
US5948619A (en) * 1997-07-31 1999-09-07 Incyte Pharmaceuticals, Inc. Human zygin-1
CA2300367A1 (fr) * 1997-08-13 1999-02-25 Chugai Research Institute For Molecular Medicine, Inc. Proteine presentant un motif zn du type doigt
EP1027436A1 (fr) * 1997-10-28 2000-08-16 Immunex Corporation Adn et polypeptides recepteurs des proteines de semaphorine a codage viral
US6130068A (en) 1998-10-26 2000-10-10 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US7214497B2 (en) 1997-10-28 2007-05-08 Immunex Corporation Viral encoded semaphorin protein receptor DNA and polypeptides
US6562949B1 (en) 1997-10-28 2003-05-13 Immunex Corporation Antibodies to viral encoded semaphorin protein receptor polypeptides
US6277565B1 (en) * 1997-11-06 2001-08-21 Millennium Pharmaceuticals, Inc. OCT-3 gene encoding transporter-like molecules
US5916753A (en) * 1997-11-13 1999-06-29 Incyte Pharmaceuticals, Inc. SH3-containing proteins
AU4930399A (en) * 1998-07-29 2000-02-21 Kyowa Hakko Kogyo Co. Ltd. Novel Polypeptide
EP1119624A2 (fr) * 1998-10-09 2001-08-01 Genset Acides nucleiques codant pour une proteine humaine cide-b et marqueurs polymorphes associes
US6355788B1 (en) 1998-10-15 2002-03-12 Zymogenetics, Inc. Follistatin-related protein zfsta2
CA2347968A1 (fr) * 1998-10-15 2000-04-20 Zymogenetics, Inc. La proteine zfsta2 apparentee a la follistatine
CA2355074A1 (fr) * 1998-12-18 2000-06-29 Incyte Pharmaceuticals, Inc. Proteines membranaires lymphocytaires
IL178921A0 (en) 1998-12-24 2007-03-08 Yeda Res & Dev Caspase-8 interacting proteins
GB9900167D0 (en) * 1999-01-06 1999-02-24 Univ Leeds Wound an tissue healing and orofacial clefting
DE19908423A1 (de) * 1999-02-26 2000-08-31 Deutsches Krebsforsch An der Entwicklung des ZNS beteiligtes Protein (TP)
WO2000053734A2 (fr) * 1999-03-09 2000-09-14 Schering Aktiengesellschaft Sequences d'acide nucleique et de proteine issues de cellules endotheliales humaines
US6558910B2 (en) 1999-09-10 2003-05-06 The Regents Of The University Of California SF, a novel family of taste receptors
AU773600B2 (en) 1999-09-10 2004-05-27 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The T2R, taste receptor family
AU1340001A (en) 1999-10-22 2001-05-08 Wyeth Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto
US20030153015A1 (en) * 2000-01-20 2003-08-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2394022A1 (fr) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Acides nucleiques, proteines et anticorps
WO2001081361A1 (fr) * 2000-04-11 2001-11-01 Cogent Neuroscience, Inc. Compositions et procedes de diagnostic et de traitement d'affections, de troubles ou de maladies entrainant la mort de cellulaire
EP1209229A1 (fr) * 2000-11-21 2002-05-29 Klaus-Peter Department of Psychiatry and Psychotherapy University of Würzburg Lesch Gène impliqué dans la schizophrénie
WO2002052005A1 (fr) 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Genes et proteines codees par ceux-ci
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP2280030A3 (fr) 2001-04-10 2011-06-15 Agensys, Inc. Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
US7189820B2 (en) 2001-05-24 2007-03-13 Human Genome Sciences, Inc. Antibodies against tumor necrosis factor delta (APRIL)
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
WO2011138392A1 (fr) 2010-05-06 2011-11-10 Novartis Ag Compositions et procédés d'utilisation d'anticorps thérapeutiques dirigés contre la protéine 6 liée à la lipoprotéine de basse densité (lrp6)
JP2013527761A (ja) 2010-05-06 2013-07-04 ノバルティス アーゲー 治療的低密度リポタンパク質関連タンパク質６（ｌｒｐ６）多価抗体の組成物および使用方法
SG11201401717VA (en) 2011-11-04 2014-05-29 Novartis Ag Low density lipoprotein-related protein 6 (lrp6) - half life extender constructs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NATURE vol. 355, 13 February 1992, LONDON, UNITED KINGDOM pages 632 - 634 M.D. ADAMS 'Sequence Identification of 2375 human brain genes' *
SCIENCE vol. 252, 21 June 1991, WASHINGTON, DC, USA pages 1651 - 1656 M.D. ADAMS ET AL. 'Complementary DNA Sequencing: Expressed Sequence Tags and Human genome Projects' *

Also Published As

Publication number Publication date
WO1993016178A2 (fr) 1993-08-19
AU3665893A (en) 1993-09-03

Similar Documents

Publication Publication Date Title
WO1993016178A3 (fr) Sequences caracteristiques du produit de transcription des genes humains
AU5914196A (en) Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
CA2053230A1 (fr) Genes de pommes de terre .alpha. -amylase
WO1999006552A3 (fr) Est 5' pour proteines secretees exprimees dans le cerveau
CA2200371A1 (fr) Gene humain npik
WO1994001548A3 (fr) Fragments d'acide nucleiques humains isoles du cerveau, des tissus surrenaux, du placenta ou de la moelle osseuse
RU93058460A (ru) Полинуклеотид, способы получения растений, геном растения, клетки, плоды, семена, способы получения семян, применение олигонуклеотида, плазмида, микроорганизм
WO1999006554A3 (fr) Est 5' pour proteines secretees exprimees dans des tissus musculaires et autres tissus mesodermiques
WO1999006550A3 (fr) Marqueurs sequences 5' exprimes pour proteines secretees exprimees dans la prostate
CY1106216T1 (el) 5´ ESTs ΓΙΑ ΜΗ ΙΣΤΟ-ΕΙΔΙΚΕΣ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ
WO1999006549A3 (fr) Est 5' pour proteines exprimees dans les testicules et autres tissus
EP0834566A3 (fr) Gène de coton
AU2240492A (en) Sequences characteristic of human gene transcription product
AU4331497A (en) Oligomers which inhibit expression of interleukin genes
WO1994008052A1 (fr) Procedes de sequençage d'oligonucleotides synthetiques contenant des liaisons internucleotidiques non-phosphodiester
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
WO2000029623A3 (fr) Acides nucleiques contenant des polymorphismes d'un seul nucleotide et utilisations de ces acides nucleiques
AU2967497A (en) Enhancement of gene expression
AU6724794A (en) GRB3-3 gene, its variants and their uses
AU1789292A (en) Yeast promoter and use thereof
WO1999046374A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO1997006259A3 (fr) Resistance aux champignons provoquant la fletrissure
EP0824150A3 (fr) Promoteur végétal et son utilisation
CA2340934A1 (fr) Nouvelle collectine
EP1146124A3 (fr) Matériau et procédé relatif à la gustducine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase